Ability of the Glasgow Prognostic Score to predict the tolerability and efficacy of platinum-combination chemotherapy among elderly patients with advanced non-small cell lung cancer .

MLA

Kazuhisa Nakashima, et al. “Ability of the Glasgow Prognostic Score to Predict the Tolerability and Efficacy of Platinum-Combination Chemotherapy among Elderly Patients with Advanced Non-Small Cell Lung Cancer .” Journal of Medical Investigation, vol. 68, no. 3/4, July 2021, pp. 260–64. EBSCOhost, https://doi.org/10.2152/jmi.68.260.

APA

Kazuhisa Nakashima, Kojiro Hata, Takamasa Hotta, Seiko Tanaka, Yuki Mitarai, Takae Okuno, Akari Tanino, Mika Nakao, Yoshihiro Amano, Megumi Hamaguchi, Tamio Okimoto, Shunichi Hamaguchi, Taishi Nagao, Noriaki Kurimoto, Takeshi Isobe, & Yukari Tsubata. (2021). Ability of the Glasgow Prognostic Score to predict the tolerability and efficacy of platinum-combination chemotherapy among elderly patients with advanced non-small cell lung cancer . Journal of Medical Investigation, 68(3/4), 260–264. https://doi.org/10.2152/jmi.68.260

Chicago

Kazuhisa Nakashima, Kojiro Hata, Takamasa Hotta, Seiko Tanaka, Yuki Mitarai, Takae Okuno, Akari Tanino, et al. 2021. “Ability of the Glasgow Prognostic Score to Predict the Tolerability and Efficacy of Platinum-Combination Chemotherapy among Elderly Patients with Advanced Non-Small Cell Lung Cancer .” Journal of Medical Investigation 68 (3/4): 260–64. doi:10.2152/jmi.68.260.